Author:
Mizuno Shinta,Nakazawa Atsushi,Ogawa Ayumi,Hisamatsu Tadakazu,Hirose Shigemichi,Tsukada Nobuhiro
Publisher
Springer Science and Business Media LLC
Subject
Gastroenterology,General Medicine
Reference10 articles.
1. Abraham C, Cho JH. Inflammatory bowel disease. Engl J Med. 2009;361:2066–78.
2. Colombel JF, Rutgeerts PJ, Sandborn WJ, et al. Adalimumab induces deep remission in patients with Crohn’s disease. Clin Gastroenterol Hepatol. 2014;12(414–22):e5.
3. Mandel MD, Miheller P, Mullner K, et al. Have biologics changed the natural history of Crohn’s disease? Dig Dis (Basel Switz). 2014;32:351–9.
4. Watanabe M, Hibi T, Mostafa NM, et al. Long-term safety and efficacy of adalimumab in Japanese patients with moderate to severe Crohn’s disease. J Crohn’s Colitis 2014.
5. Fink AS, Kosakowski CA, Hiatt JR, Cochran AJ. Periappendicitis is a significant clinical finding. Am J Surg. 1990;159:564–8.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献